WestminsterResearch

Items where Author is Milton, Nathaniel G.N.

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] RSSPD [feed] Atom
Group by: Date | Item Type | Creators | No Grouping
Number of items: 35.

Article

Milton, Nathaniel G.N. and Harris, J. Robin (2009) Polymorphism of amyloid-ß fibrils and its effects on human erythrocyte catalase binding. Micron, 40 (8). pp. 800-810. ISSN 0968-4328

Milton, Nathaniel G.N. (2008) Homocysteine inhibits hydrogen peroxide breakdown by catalase. Open Enzyme Inhibition Journal, 1 . pp. 34-41. ISSN 1874-9402

Milton, Nathaniel G.N. (2005) Phosphorylated amyloid-ß: the toxic intermediate in Alzheimer's disease neurodegeneration. Subcellular Biochemistry, 38 . pp. 381-402. ISSN 0306-0225

Milton, Nathaniel G.N. (2004) Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment. Drugs & Aging, 21 (2). pp. 81-100. ISSN 1170-229X

Milton, Nathaniel G.N. (2002) Anandamide and noladin ether prevent neurotoxicity of the human amyloid-ß peptide. Neuroscience Letters, 332 (2). pp. 127-130. ISSN 0304-3940

Milton, Nathaniel G.N. (2002) The amyloid-β peptide binds to cyclin B1 and increases human cyclin-dependent kinase-1 activity. Neuroscience Letters, 322 (2). pp. 131-133. ISSN 0304-3940

Byrne, D.J. and Jagroop, I.A. and Montgomery, H.E. and Thomas, M. and Mikhailidis, D.P. and Milton, Nathaniel G.N. and Winder, A.F. (2002) Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk. Journal of Clinical Pathology, 55 (4). pp. 280-285. ISSN 0021-9746

Milton, Nathaniel G.N. (2001) Inhibition of catalase activity with 3-amino-triazole enhances the cytotoxicity of the Alzheimer’s amyloid-ß peptide. NeuroToxicology, 72 (6). pp. 767-774. ISSN 0161-813X

Milton, Nathaniel G.N. (2001) Phosphorylation of amyloid-ß at the serine 26 residue by human cdc2 kinase. NeuroReport, 12 (17). pp. 3839-3844. ISSN 0959-4965

Milton, Nathaniel G.N. and Mayor, Neema P. and Rawlinson, John (2001) Identification of amyloid-ß binding sites using an antisense peptide approach. NeuroReport, 12 (11). pp. 2561-2566. ISSN 0959-4965

Harris, J. Robin and Milton, Nathaniel G.N. (2010) Cholesterol in Alzheimer's disease and other amyloidogenic disorders. Subcellular Biochemistry, 51 . pp. 47-75. ISSN 0306-0225

Milton, Nathaniel G.N. and Harris, J. Robin (2010) Human islet amyloid polypeptide fibril binding to catalase: a transmission electron microscopy and microplate study. ScientificWorldJournal, 10 . pp. 879-893. ISSN 1537-744X

Milton, Nathaniel G.N. and Chilumuri, Amrutha and Rocha-Ferreira, Eridan and Nercessian, Amanda N. and Ashioti, Maria (2012) Kisspeptin prevention of Amyloid-β Peptide neurotoxicity in vitro. ACS chemical neuroscience, 3 (9). pp. 706-719. ISSN 1948-7193

Chilumuri, Amrutha and Ashioti, Maria and Nercessian, Amanda N. and Milton, Nathaniel G.N. (2013) Immunolocalization of kisspeptin associated with amyloid-β deposits in the pons of an Alzheimer’s disease patient. Journal of Neurodegenerative Diseases, 2013 . Article ID 879710. ISSN 2090-858X

Milton, Nathaniel G.N. and Harris, J. Robin (2013) Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide. Micron, 44 . pp. 246-253. ISSN 0968-4328

Chilumuri, Amrutha and Odell, Mark and Milton, Nathaniel G.N. (2013) Benzothiazole aniline-tetra(ethylene glycol) and 3-amino-1,2,4-triazole inhibit neuroprotection against amyloid peptides by catalase overexpression in vitro. ACS Chemical Neuroscience, 4 (11). pp. 1501-1512. ISSN 1948-7193

Chilumuri, Amrutha and Milton, Nathaniel G.N. (2013) The role of neurotransmitters in protection against amyloid-β toxicity by KiSS-1 overexpression in SH-SY5Y neurons. ISRN Neuroscience, 2013 . Article ID 253210. ISSN 2314-4661

Gillespie, Scarlett and Milton, Nathaniel G.N. and Ashioti, Maria and Gavins, Felicity N.E. (2013) Sulforaphane alters cerebral leukocyte endothelial cell interactions post global ischaemia reperfusion. FASEB Journal, 27 . 687.18. ISSN 0892-6638

Milton, Nathaniel G.N. (2012) Kissorphin, a hexapeptide derivative of Kisspeptin, acts via Neuropeptide FF receptors to inhibit cyclic adenosine monophosphate release but has no Gonadotrophin-Releasing-Hormone releasing activity. Endocrine Abstracts, 28 . OC2.3. ISSN 1470-3947

Milton, Nathaniel G.N. (2012) In vitro activities of Kissorphin, a novel hexapeptide KiSS-1 derivative, in neuronal cells. Journal of Amino Acids, 2012 . Article ID 691463. ISSN 2090-0104

Harris, J. Robin and Milton, Nathaniel G.N. (2012) Introduction and technical survey: protein aggregation and fibrillogenesis. Subcellular Biochemistry, 65 . pp. 3-25. ISSN 0306-0225

Chilumuri, Amrutha and Odell, Mark and Milton, Nathaniel G.N. (2013) The neuroprotective role of catalase overexpression in SH-SY5Y cells against beta-amyloid and H2O2 toxicity. Alzheimer's & Dementia , 9 (4). P361. ISSN 1552-5260

Chilumuri, Amrutha and Markiv, Anatoliy and Milton, Nathaniel G.N. (2014) Immunocytochemical staining of endogenous nuclear proteins with the HIS-1 anti-poly-histidine monoclonal antibody: a potential source of error in His-tagged protein detection. Acta Histochemica . ISSN 0065-1281 (In Press)

Book Section

Milton, Nathaniel G.N. (2006) Anti-sense peptides. In: Harris, J.R. and Graham, J. and Rickwood, D., (eds.) Cell biology protocols. John Wiley, Chichester, pp. 353-358. ISBN 9780470847589

Milton, Nathaniel G.N. (2006) Interactions between amyloid-ß and enzymes. In: Harris, J.R. and Graham, J. and Rickwood, D., (eds.) Cell biology protocols. John Wiley, Chichester, pp. 359-363. ISBN 9780470847589

Milton, Nathaniel G.N. (2006) Amyloid-ß phosphorylation. In: Harris, J.R. and Graham, J. and Rickwood, D., (eds.) Cell biology protocols. John Wiley, Chichester, pp. 364-368. ISBN 9780470847589

Milton, Nathaniel G.N. and Harris, J. Robin (2014) Polymorphism of amyloid fibrils and their complexes with catalase. In: Uversky, V.N. and Lyubchenko, Y.L., (eds.) Bio-nanoimaging: protein misfolding and aggregation. Academic Press, Boston, pp. 255-262. ISBN 9780123944313

Conference or Workshop Item

Ashioti, Maria and Getting, Stephen J. and Locke, Ian C. and Milton, Nathaniel G.N. (2013) Neuroprotective efficacy of the endogenous neuropeptide Urocortin in a oxygen-glucose deprivation model of transient cerebral ischaemia with reperfusion. In: British Neuroscience Association 22nd Biennial Meeting, 7th-10th April 2013, London. (Submitted)

Patent

Milton, Nathaniel G.N. (2005) Phosphorylated Amyloid-ß 1-43 protein and its use in the treatment of Alzheimer's disease. European Patent Application Number EP 04025899.8 - R51(4) intention to Grant issued 19/04/2007 (Publication Number EP1538163).

Milton, Nathaniel G.N. (2004) Peptides for use in the treatment of Alzheimer's disease. United States Patent Application Number US 10/415383 (Publication Number US 2004/0072753).

Milton, Nathaniel G.N. (2003) Peptides for use in the treatment of Alzheimer's disease. European Patent Application Number EP 01980678.5 – R51(4) intention to Grant issued 19/02/2007 (Publication Number EP1363939).

Milton, Nathaniel G.N. (2002) Peptides for use in the treatment of Alzheimer's disease. International Patent Application Publication Number WO 02/36614.

Nathaniel G.N. Milton (2011) Kissorphin Peptides used in the treatment of Alzheimer’s Disease, Creutzfeldt Jakob Disease or Diabetes Mellitus P. WO2011/144714 A1.

Nathaniel G.N. Milton (2011) Kissorphin Peptides used in the treatment of Alzheimer’s Disease, Creutzfeldt Jakob Disease or Diabetes Mellitus P. EP2388012A1.

Nathaniel Milton (2013) Kissorphin peptides for use in the treatment of Alzheimer's disease, Creutzfeldt-Jakob disease or diabetes mellitus. United Kingdom Patent Application Publication Number GB2493313.

This list was generated on Thu Aug 28 10:12:41 2014 BST.